Search
for
Sort by
Research 30 of 842
- [A new treatment for androgenetic alopecia : platelet-rich plasma injections].
- Bioactive peptides derived from food proteins preventing lifestyle‐related diseases
- COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Lisinopril-Induced Alopecia: A Case Report
- [Drug induced alopecia].
- Investigating drug induced alopecia
- Pharmacotherapy for Keloids and Hypertrophic Scars
- Analysis and clinical determinants of post-COVID-19 syndrome in the Lombardy region: evidence from a longitudinal cohort study
- Association of common medication with prostate-specific antigen level in 45-year-old German men: Results of the PROBASE trial
- Comparison of the pharmacoeconomic profiles of treatment regimens for field pattern actinic keratoses
- Retrospective analysis of the risk of hyperkalaemia in women older than 65 years of age prescribed spironolactone for female-pattern hair loss
- QUINAPRIL
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- PD35-08 ASSOCIATION OF COMMON MEDICATION WITH PROSTATE-SPECIFIC ANTIGEN LEVEL IN 45-YEAR-OLD GERMAN MEN: RESULTS OF THE PROBASE TRIAL
- The effect of the combined drug Yuperio with bisoprolol on the dynamics of the heart with dilation of the left chambers, the development of which is due to non-compactness of the myocardium of the left ventricle
- Repurposing of approved cardiovascular drugs
- Reversible ageusia associated with losartan
- Spironolactone
- Refractory Postsurgical Hypothyroidism in Nephrotic Syndrome
- Sheehan Syndrome Leading to Acute Systolic and Diastolic Heart Failure: A Case Report
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- New 5?-reductase inhibitors: In vitro and in vivo effects
- New Progesterone Esters as 5.ALPHA.-Reductase Inhibitors.
- 5α‐reductase inhibitors: Evaluation of their potential confounding effect on GC‐C‐IRMS doping analysis
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy